Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
Audience: Cardiology and endocrinology healthcare professionals
FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of…
November 23rd, 2009
Posted in
Warnings